Article

BioLargo, Inc. is advancing technologies in infrastructure, environmental remediation, and medical innovations in 2025, focusing on capital efficiency and long-term value creation. Key initiatives include the installation of an Aqueous Electrostatic Concentrator in New Jersey to address PFAS contamination, a collaboration for Cellinity battery factories, and the expansion of Clyra Medical's production capabilities for iodine-based medical devices. As the company prepares for 2026, it aims to align with global trends in sustainability and health innovation, positioning itself for significant commercial growth.